We are live on ! Find out more
VCYT icon

Veracyte

187 hedge funds and large institutions have $1.28B invested in Veracyte in 2019 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 70 increasing their positions, 57 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 57

9.82% more ownership

Funds ownership: 99.99%109.82% (+9.8%)

4% less funds holding

Funds holding: 195187 (-8)

7% less capital invested

Capital invested by funds: $1.37B → $1.28B (-$90.3M)

15% less first-time investments, than exits

New positions opened: 41 | Existing positions closed: 48

29% less funds holding in top 10

Funds holding in top 10: 75 (-2)

36% less call options, than puts

Call options by funds: $720K | Put options by funds: $1.12M

Holders
187
Holders Change
-8
Holders Change %
-4.1%
% of All Funds
4.1%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.11%
New
41
Increased
70
Reduced
57
Closed
48
Calls
$720K
Puts
$1.12M
Net Calls
-$401K
Net Calls Change
-$362K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$104M +$8.7M +327,145 +8%
GGHC
2
Gilder Gagnon Howe & Co
New York
$91.8M -$1.25M -46,825 -1%
Invesco
3
Invesco
Georgia
$77.4M +$6.33M +237,962 +8%
William Blair Investment Management
4
William Blair Investment Management
Illinois
$70.3M +$58.5M +2,200,038 +302%
NAMA
5
Nikko Asset Management Americas
New York
$66.3M +$16.4M +615,988 +29%
Sumitomo Mitsui Trust Group
6
Sumitomo Mitsui Trust Group
Japan
$66.3M +$43.4M +1,633,287 +144%
AIM
7
ARK Investment Management
Florida
$62M -$12.1M -453,855 -15%
Vanguard Group
8
Vanguard Group
Pennsylvania
$61.1M +$6.57M +247,035 +11%
State Street
9
State Street
Massachusetts
$50.8M +$5.18M +194,825 +10%
VVM
10
Versant Venture Management
California
$28.9M -$32.1M -1,205,408 -50%
N
11
Nuveen
North Carolina
$27M -$1.36M -51,131 -4%
Wellington Management Group
12
Wellington Management Group
Massachusetts
$25.1M +$27.9M +1,047,487 New
FCM
13
Farallon Capital Management
California
$24M +$17.3M +650,000 +186%
EAM
14
Eventide Asset Management
Massachusetts
$22.3M
PAMU
15
Pictet Asset Management (UK)
United Kingdom
$21.5M +$23.9M +897,556 New
Fiera Capital (Canada)
16
Fiera Capital (Canada)
Quebec, Canada
$21.3M -$858K -32,274 -4%
Goldman Sachs
17
Goldman Sachs
New York
$18.4M +$1.18M +44,231 +6%
BAMCO Inc
18
BAMCO Inc
New York
$17.9M +$1.95M +73,382 +11%
WRF
19
Waddell & Reed Financial
Kansas
$16.6M +$18.5M +693,630 New
Prudential Financial
20
Prudential Financial
New Jersey
$16.1M -$2.76M -103,893 -13%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$15.7M +$9.8M +368,403 +128%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$15.3M +$1.68M +63,019 +11%
NCGI
23
Next Century Growth Investors
Minnesota
$15.2M -$3.17M -119,324 -16%
Northern Trust
24
Northern Trust
Illinois
$14.9M +$5.88M +220,869 +55%
Allianz Asset Management
25
Allianz Asset Management
Germany
$11.4M -$595K -22,372 -4%

VCYT Hedge Fund Activity: Q3 2019 in Review

187 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q3 2019, worth a combined $1.28B — down 6.6% from $1.37B a quarter earlier.

Sellers outnumbered buyers: 48 funds closed out of VCYT and 41 opened new positions — a net loss of 7 holders — while 57 trimmed existing stakes and 70 added.

The largest buyer was William Blair Investment Management, adding an estimated $58.5M. The largest seller was Versant Venture Management, cutting an estimated $32.1M.

  • 187 institutional investors held Veracyte (VCYT) as of Q3 2019, down from 195 in Q2 2019.
  • Funds reported $1.28B of Veracyte stock for Q3 2019, down 6.6% quarter-over-quarter.
  • 41 funds opened new Veracyte positions in Q3 2019 and 48 closed out, a net change of -7 holders.
  • The largest Veracyte buyer in Q3 2019 was William Blair Investment Management, an estimated $58.5M added.
  • The largest Veracyte seller in Q3 2019 was Versant Venture Management, an estimated $32.1M sold.

Based on aggregated 13F filings for Q3 2019.